Cannabis Bioscience International Holdings (CBIH) Non-Current Assets (2023 - 2025)
Cannabis Bioscience International Holdings' (CBIH) quarterly Non-Current Assets came in at $2795.0 in Q2 2025, down 92.16% year-on-year from $35670.0 in Q2 2024, and down 74.82% quarter-over-quarter from $11100.0 in Q1 2025.
Cannabis Bioscience International Holdings (CBIH) Non-Current Assets (2023 - 2025) Analysis & Trends
Cannabis Bioscience International Holdings has disclosed Non-Current Assets across 3 years of filings, most recently posting $2795.0 for Q2 2025.
- Non-Current Assets for Q2 2025 came in at $2795.0, down 92.16% year-over-year; the trailing twelve-month figure through Feb 2026 was $2795.0 (down 97.02% YoY), and the FY2025 annual result was $2795.0, down 92.16% from the prior year.
- Non-Current Assets came in at $2795.0 for Q2 2025 at Cannabis Bioscience International Holdings, down from $11100.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $82103.0 in Q4 2023 to a low of $2795.0 in Q2 2025.
- The 3-year median for Non-Current Assets is $25728.5 (2023), against an average of $34751.6.
- Across the five-year window, Non-Current Assets soared 49.12% in 2024 and slumped 92.16% in 2025, its largest moves.
- Cannabis Bioscience International Holdings' Non-Current Assets stood at $82103.0 in 2023, then tumbled by 76.44% to $19347.0 in 2024, then plunged by 85.55% to $2795.0 in 2025.
- The last three Non-Current Assets figures came in at $2795.0 (Q2 2025), $11100.0 (Q1 2025), and $19347.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Cannabis Bioscience International Holdings | - | - | 8,160.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2025 | 2,795.00 |
| Feb 28, 2025 | 11,100.00 |
| Nov 30, 2024 | 19,347.00 |
| Aug 31, 2024 | 27,537.00 |
| May 31, 2024 | 35,670.00 |
| Feb 29, 2024 | 75,541.00 |
| Nov 30, 2023 | 82,103.00 |
| May 31, 2023 | 23,920.00 |